A bench of Chief Justice G Rohini and Justice R S Endlaw issued notices to the Union and Delhi government as well as National AIDS Control Organization (NACO) and sought their replies by July 22 on the plea which has sought directions to the authorities to provide "uninterrupted" service with regard to treatment to People Living with HIV/AIDS (PLHIV).
At present there are nine ART centres in Delhi, while CD4 machines are installed at Ram Manohar Lohia (RML), AIIMS, LNJP and Safdarjung hospitals, besides the National Institute of Communicable Diseases (NICD), it said.
However, no CD4 kits are available at RML which was also responsible for conducting CD4 tests for two other centres - Ambedkar and Kalawati Saran hospitals, it said and added "so, effectively presently CD4 tests are not being conducted for three hospitals in Delhi due to non-availability of CD4 kits where around 20,000 PLHIV are registered".
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
